Senti Biosciences

Public

South San Francisco, CaliforniaBiotechhttps://www.sentibio.com

Senti Biosciences is now publicly traded

The data on this page reflects Senti Biosciences's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Convertible Debt

May 20, 2026

Total Funding Raised

$279.38M

Company Overview

Senti Biosciences operates in Biotech and is based in South San Francisco, California. It has raised $279.38M.

Senti Bio is a biotechnology company specializing in the development of next-generation cell and gene therapies using innovative gene circuit platform technologies to combat difficult diseases.

Sector

Biotech

AI Layer

Non-AI

Senti Biosciences Comparables

Compare Senti Biosciences with similar companies based on industry and business-model similarity.

Senti Biosciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
A2 Biotherapeutics	80%	Demo
Wugen	76%	Demo
Cartherics	74%	Demo

Book a demo to see all comparables

For institutional investors. Book with your work email.

Senti Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Convertible Debt	May 20, 2026	Demo	Demo	Demo	Demo
PIPE	Dec 5, 2024	Demo	Demo	Demo	Demo
Grant	Jun 1, 2024	Demo	Demo	Demo	Demo
Reverse Merger	Jun 8, 2022	Demo	Demo	Demo	Demo
Convertible Debt	May 19, 2022	Demo	Demo	Demo	Demo
Series B	Jan 6, 2021	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Senti Biosciences Investors

Notable investors and investment history

Senti Biosciences investors
Investor	Rounds
Matrix	Series B
Smilegate Investment	Series B
Nest.Bio	Series A, Series B
LifeSci Venture Partners	Series B
KB Investment	Series B
Omega Funds	Series A
Ridgeback Capital	Series B